Cyclerion Therapeutics Inc Cash Flow Quality Index
Latest as of December 2024:
0.68x
Cyclerion Therapeutics Inc cash flow quality index. Cyclerion Therapeutics Inc (CYCN) has a Cash Flow Quality Index of 0.68x as of December 2024. Operating cash flow of $360.00K is below net income of $530.00K, suggesting accrual-heavy earnings not yet converted to cash. See CYCN FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
0.68x
Operating CF / Net Income
Operating Cash Flow
$360.00K
USD
Net Income
$530.00K
USD
Data as of
Dec 2024
Most recent filing
Cyclerion Therapeutics Inc Cash Flow Quality Index by Year (None–None)
Cyclerion Therapeutics Inc cash flow quality index by year from None to None. Year-by-year earnings quality comparison for Cyclerion Therapeutics Inc. For the full cash flow conversion analysis, see Cyclerion Therapeutics Inc cash flow conversion.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.